Other names: Aranesp
Categories: Prescription Medication
Description:
Darbepoetin alfa is a long-acting form of erythropoietin used to treat anemia, mainly in patients with chronic kidney disease or those receiving chemotherapy. Like epoetin alfa, it stimulates the bone marrow to make more red blood cells, but it lasts longer in the body, so injections are needed less often. It can reduce the need for blood transfusions and improve symptoms like fatigue and weakness. However, it carries risks such as high blood pressure, blood clots, stroke, or heart problems
Treatment For:
AI generated Summary: Based on the provided information, there are no user reviews available for the treatment 'Darbepoetin Alfa' against the disease 'Anemia'. The author has not provided any review or rating for this treatment. Therefore, it is not possible to determine the effectiveness of 'Darbepoetin Alfa' in treating 'Anemia' from the given data.
Darbepoetin alfa is used for anemia because it stimulates the bone marrow to produce more red blood cells, similar to epoetin alfa, but with a longer half-life. This means it can be given less frequently, which is more convenient for patients. It is commonly used in anemia from chronic kidney disease or chemotherapy to reduce the need for blood transfusions.
The information, including but not limited to, text, graphics, images and other material contained on this website/app are for informational purposes only. No material on this site/app is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website/app.
Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.
